Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel Diseases
NCT02020382 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 325
Last updated 2018-05-21
Summary
The purpose of this study is to assess the diagnostic value of microRNAs in IBD colon (ulcerative colitis or Crohn's disease) in adults as compared to healthy controls (and non-IBD colitis)
Conditions
- Ulcerative Colitis
- Crohn Disease
- Healthy
- Non-IBD Colitis
Interventions
- DEVICE
-
qPCR diagnostic KIT of microRNAS
testing qPCR diagnostic KIT of microRNAS from colonic biopsies
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Xavier Treton, MD,PhD · Assistance Publique - Hôpitaux de Paris
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-12-31
- Primary Completion
- 2016-12-31
- Completion
- 2017-12-31
Countries
- France
Study Locations
More Related Trials
-
Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease
NCT05733845 ·Status: RECRUITING ·Phase: NA
-
Immunological Characteristics of Preclinical IBD
NCT05698745 ·Status: RECRUITING
-
IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE
NCT03809728 ·Status: RECRUITING ·Phase: NA
-
Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease
NCT07292012 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Identify Specific Peripheral Blood Mononuclear Cell (PBMC) MiRNA as Biomarkers for Inflammatory Bowel Disease (IBD)
NCT04256538 ·Status: COMPLETED
-
Study Evaluating the Persistence, Efficacy and Tolerability of Methotrexate in Inflammatory Bowel Disease Patients
NCT05927064 ·Status: COMPLETED
-
Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD)
NCT01289366 ·Status: COMPLETED
-
The Associations of Plasminogen Activator Inhibitor-1 Gene Polymorphisms With Crohn's Disease in Chinese Patients
NCT06935942 ·Status: COMPLETED
-
Predicting IBD Treatment Outcomes With Gut Microbiome Analysis
NCT06453720 ·Status: RECRUITING
-
Impact of the Fecal Flora Transplantation on Crohn's Disease
NCT02097797 ·Status: COMPLETED ·Phase: NA
-
A Multicentered Prospective Cohort Study of Chinese IBD Patients
NCT05386290 ·Status: UNKNOWN
-
Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy
NCT03359642 ·Status: COMPLETED ·Phase: NA
-
MIcroorganisms as Triggers in Acute Severe Ulcerative Colitis and Their Influence on Medical Therapy Efficacy: a Multi-omics Pilot Approach.
NCT04272307 ·Status: UNKNOWN
-
A Study on the Associations Between Microribonucleic Acid Gene Polymorphisms and Crohn's Disease
NCT06935929 ·Status: COMPLETED
-
Comprehensive DNA Methylation Profiling in Crohn's Disease
NCT03272152 ·Status: UNKNOWN
-
Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease
NCT05598489 ·Status: UNKNOWN
-
Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143)
NCT01349920 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
NCT01369329 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Intestinal Secretion of Antibodies and Auto-antibodies Associated With Crohn's Disease
NCT00769236 ·Status: COMPLETED ·Phase: NA
-
Identification by Cytometry by Mass of Predictive Immunological Profiles of Answer to Treatmentby Biotherapics for Patients With Crohn's Disease
NCT03712826 ·Status: WITHDRAWN ·Phase: NA
-
Gene Expression in Inflammatory Bowel Disease
NCT01171872 ·Status: ENROLLING_BY_INVITATION
-
Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
NCT06252493 ·Status: RECRUITING
-
Abnormal Fecal Microbiota in Healthy Subjects at High Risk for Crohn's Disease
NCT02826330 ·Status: COMPLETED
-
Early Immunosuppressants in Crohn's Disease
NCT00546546 ·Status: COMPLETED ·Phase: PHASE4
-
Unveiling the Microbial Impact on Intestinal Fibrosis
NCT06073288 ·Status: NOT_YET_RECRUITING